Berkshire Hathaway’s cash reserves surged to $381.7 billion by the end of September 2025, according to its third-quarter results.
The jump came despite a $9.7 billion investment in chemicals and vinyl products maker OxyChem, its biggest deal in years.
Buffett also sold $6.1 billion worth of shares during the quarter, even as the company’s cash pile kept growing.
